Medical Aesthetics Market Share Worth Nearly $16 Billion by 2028 - Exclusive Report by The Insight Partners


Download Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPHE100000984





Order a Copy of this Report at https://www.theinsightpartners.com/buy/TIPHE100000984


In March 2021, Solta Medical business announced the U.S. launch of the Clear + Brilliant Touch laser, the company's next-generation Clear + Brilliant laser. The Clear + Brilliant Touch laser delivers a customized and more comprehensive treatment protocol by providing patients of all ages and skin types with the benefits of two wavelengths.

In January 2021, Galderma launched Face for Change, a program designed to impact communities around the country positively. In partnership with Dress for Success and The Skin Cancer Foundation, this purpose-driven program will allow users of Dysport (abobotulinumtoxinA) for injection to give back with each treatment received.

In January 2021, Allergan Aesthetics announced that they had entered into a warrant agreement with Cypris Medical, a privately held medical device company in Chicago. After completing a clinical trial in 2021, Allergan Aesthetics will have the right to exercise an option to acquire Cypris Medical, including the company's Xact device. The planned clinical trial will evaluate the safety and effectiveness of Xact in treating midface descent and neck lifts.



Go through further research published by The Insight Partners:

Facial Aesthetics Market - Global Analysis and Forecast to 2030

Laser Aesthetics Market - Global Analysis and Forecast to 2030



Contact Us:
If you have any queries about this report or if you would like further information, please contact us:


Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.